{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:38:09Z","timestamp":1770903489028,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["P30RR030927\/P30GM103392"],"award-info":[{"award-number":["P30RR030927\/P30GM103392"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["P20RR018789\/P20GM103465"],"award-info":[{"award-number":["P20RR018789\/P20GM103465"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL083151"],"award-info":[{"award-number":["R01 HL083151"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00432-016-2272-7","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T16:22:15Z","timestamp":1474042935000},"page":"209-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cancer incidence in patients with hereditary hemorrhagic telangiectasia"],"prefix":"10.1007","volume":"143","author":[{"given":"Christine W.","family":"Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam W.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Lee","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin P. H.","family":"Vary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"key":"2272_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","volume":"432","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432:332\u2013337","journal-title":"Nature"},{"key":"2272_CR2","doi-asserted-by":"publisher","first-page":"e72407","DOI":"10.1371\/journal.pone.0072407","volume":"8","author":"MJ Breen","year":"2013","unstructured":"Breen MJ, Moran DM, Liu W, Huang X, Vary CPH, Bergan RC (2013) Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors. Plos One 8:e72407","journal-title":"Plos One"},{"key":"2272_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, Mackenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"2272_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.publhealth.23.092101.134534","volume":"23","author":"RA Deyo","year":"2002","unstructured":"Deyo RA (2002) Cascade effects of medical technology. Annu Rev Public Health 23:23\u201344","journal-title":"Annu Rev Public Health"},{"key":"2272_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1158\/1055-9965.EPI-13-0665","volume":"23","author":"CW Duarte","year":"2014","unstructured":"Duarte CW, Murray K, Lucas FL, Fairfield K, Miller H, Brooks P, Vary CP (2014) Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia. Cancer Epidemiol Biomarkers Prev 23:117\u2013125","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2272_CR6","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1002\/cncr.28148","volume":"119","author":"KJ Fisher","year":"2013","unstructured":"Fisher KJ, Lee JH, Ferrante JM, McCarthy EP, Gonzalez EC, Chen R, Love-Jackson K, Roetzheim RG (2013) The effects of primary care on breast cancer mortality and incidence among medicare beneficiaries. Cancer 119:2964\u20132972","journal-title":"Cancer"},{"key":"2272_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10585-010-9356-6","volume":"28","author":"M Lakshman","year":"2011","unstructured":"Lakshman M, Huang X, Ananthanarayanan V, Jovanovic B, Liu Y, Craft CS, Romero D, Vary CP, Bergan RC (2011) Endoglin suppresses human prostate cancer metastasis. Clin Exp Metastasis 28:39\u201353","journal-title":"Clin Exp Metastasis"},{"key":"2272_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345\u2013351","journal-title":"Nat Genet"},{"key":"2272_CR9","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1158\/0008-5472.CAN-10-2665","volume":"71","author":"D Romero","year":"2011","unstructured":"Romero D, O\u2019Neill C, Terzic A, Contois L, Young K, Conley BA, Bergan RC, Brooks PC, Vary CPH (2011) Endoglin regulates cancer-stromal cell interactions in prostate tumors. Cancer Res 71:3482\u20133493","journal-title":"Cancer Res"},{"key":"2272_CR10","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-12-0098","volume":"18","author":"LS Rosen","year":"2012","unstructured":"Rosen LS, Hurwitz HI, Wong MK, Goldman J, Mendelson DS, Figg WD, Spencer S, Adams BJ, Alvarez D, Seon BK, Theuer CP, Leigh BR, Gordon MS (2012) A phase I first-in-human study of TRC105 (anti-endoglin antibody) in patients with advanced cancer. Clin Cancer Res 18:4820\u20134829","journal-title":"Clin Cancer Res"},{"key":"2272_CR11","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2174\/138161206776361219","volume":"12","author":"C Sabba","year":"2006","unstructured":"Sabba C, Gallitelli M, Pasculli G, Suppressa P, Resta F, Tafaro GE (2006) HHT: a rare disease with a broad spectrum of clinical aspects. Curr Pharm Des 12:1217\u20131220","journal-title":"Curr Pharm Des"},{"key":"2272_CR12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1538-7836.2007.02531.x","volume":"5","author":"C Sabba","year":"2007","unstructured":"Sabba C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, Dicuonzo F, Guant G (2007) Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 5:1149\u20131157","journal-title":"J Thromb Haemost"},{"key":"2272_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1148\/radiol.2293031482","volume":"230","author":"S Saluja","year":"2004","unstructured":"Saluja S, White RI (2004) Hereditary hemorrhagic telangiectasia of the liver: hyperperfusion with relative ischemia\u2013poverty amidst plenty. Radiology 230:25\u201327","journal-title":"Radiology"},{"key":"2272_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu\u2013Osler\u2013Weber syndrome). Am J Med Genet 91:66\u201367","journal-title":"Am J Med Genet"},{"key":"2272_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1158\/1055-9965.EPI-14-0923","volume":"24","author":"B Trabert","year":"2015","unstructured":"Trabert B, Wentzensen N, Felix AS, Yang HP, Sherman ME, Brinton LA (2015) Metabolic syndrome and risk of endometrial cancer in the United States: a study in the SEER-medicare linked database. Cancer Epidemiol Biomarkers Prev 24:261\u2013267","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-016-2272-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-016-2272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:35:29Z","timestamp":1589636129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-016-2272-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2272"],"URL":"https:\/\/doi.org\/10.1007\/s00432-016-2272-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]},"assertion":[{"value":"20 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project was considered exempt from human subjects research by the Maine Medical Center IRB due to use of only deidentified data. These data were provided by SEER Medicare under an approved data use agreement, and this manuscript has been approved by SEER Medicare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"This is not applicable as this research was considered exempt from human subjects research by the Maine Medical Center IRB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}